![Monil Shah](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Monil Shah
Corporate Officer/Principal bij
IMUGENE LIMITED
Vermogen: 8 688 $ op 31-08-2026
Profiel
Monil Shah was the founder of Ventrus Biosciences, Inc. (founded in 2011) where he held the title of Vice President-Clinical Research & Development from 2011 to 2014.
He is currently the Chief Business Officer at Imugene Ltd. (since 2021) and the Chief Development Officer at WindMIL Therapeutics, Inc. He previously served as the Chief Operating Officer at IRX Therapeutics, Inc. and Eterna Therapeutics LLC (from 2017 to 2018).
Dr. Shah also held the position of VP-Operations & Clinical Development at LTR Pharma Ltd. Dr. Shah obtained undergraduate and doctorate degrees from Rutgers State University of New Jersey.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
IMUGENE LTD 0,03% | 30-06-2025 | 178.279 ( 0,03% ) | 8 688 $ | 31-08-2026 |
Actieve functies van Monil Shah
| Bedrijven | Functie | Begin |
|---|---|---|
| IMUGENE LIMITED | Corporate Officer/Principal | 10-06-2021 |
WindMIL Therapeutics, Inc.
 WindMIL Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops and offers immunotherapies to treat cancer patients | Corporate Officer/Principal | - |
Eerdere bekende functies van Monil Shah
| Bedrijven | Functie | Einde |
|---|---|---|
Eterna Therapeutics LLC
 Eterna Therapeutics LLC Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops cytokine-based drugs for the treatment of cancer | Operationeel Directeur | 01-10-2018 |
Ventrus Biosciences, Inc.
 Ventrus Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets phamaceutical products | Oprichter | 01-03-2014 |
IRX Therapeutics, Inc.
 IRX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Operationeel Directeur | - |
| LTR PHARMA LIMITED | Corporate Officer/Principal | - |
Opleiding van Monil Shah
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
40
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
IRX Therapeutics, Inc.
IRX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Health Technology |
Ventrus Biosciences, Inc.
Ventrus Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets phamaceutical products | Health Technology |
Imugene Ltd.
 Imugene Ltd. BiotechnologyHealth Technology Operates as a a clinical stage immuno-oncology company | Health Technology |
Rutgers State University of New Jersey
 Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
WindMIL Therapeutics, Inc.
WindMIL Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops and offers immunotherapies to treat cancer patients | Health Technology |
Eterna Therapeutics LLC
Eterna Therapeutics LLC Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops cytokine-based drugs for the treatment of cancer | Health Technology |
Ltr Pharma Ltd.
 Ltr Pharma Ltd. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
